7 completed, 3 unknown, 1 recruiting, 1 terminated. 12 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 7, Unknown 3, Recruiting 1, Terminated 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Gastritis: new trials by email Literature Review of Gastritis trials Research Report on Gastritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Holy Basil in The Treatment of Dyspepsia Holy basil extract - Dyspepsia and Other Specified Disorders of Function of Stomach | Phase 2 / Phase 3 | Recruiting | Mahidol University | 27 | 2026-02-13 | 2026-03-24 |
| 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication Vonoprazan, Amoxicillin, Clarithromycin - Helicobacter Pylori Infection, Gastritis | Phase 3 | Completed | Alexandria University | 326 | 2024-06-30 | 2025-02-11 |
| Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis HIP2101, RLD2101, HPP2101 - Gastritis | Phase 3 | Completed | Hanmi Pharmaceutical Company Limited | 326 | 2021-08-09 | 2022-07-14 |
| A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 CKD-495 75mg, Artemisia Herb 95% Ethanol Soft Ext.(20→1) 60mg, Placebo of the CKD-495 75mg - Gastritis | Phase 3 | Completed | Chong Kun Dang Pharmaceutical | 242 | 2020-01-06 | 2021-07-02 |
| Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis DWC20155, DWC20156, placebo of DWC20155 - Gastritis | Phase 3 | Terminated | Daewoong Pharmaceutical Co. LTD. | 230 | 2017-07-03 | 2019-06-26 |
| Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study Esomeprazole, Amoxicillin-Potassium Clavulanate Combination, Clarithromycin - H. Pylori Infection | Phase 3 | Unknown | Chinese University of Hong Kong | 96 | 2015-03-01 | 2017-05-05 |
| BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis RHB-102, Placebo Oral Tablet - Gastroenteritis, Gastritis | Phase 3 | Completed | RedHill Biopharma Limited | 330 | 2014-12-08 | 2019-02-20 |
| Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein Carbohydrate plus whey protein enriched drink - Peptic Ulcer, Gastritis | Phase 2 / Phase 3 | Completed | Federal University of Mato Grosso | 30 | 2013-02-01 | 2013-04-10 |
| Helicobacter Eradication Relief of Dyspeptic Symptoms Amoxicillin, Clarythromycin, Omeprazole for ten days - Functional Dyspepsia | Phase 3 | Completed | Hospital de Clinicas de Porto Alegre | 407 | 2006-10-01 | 2018-03-01 |
| Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection rabeprazole, amoxicillin, clarithromycin, metronidazole - Helicobacter Infections, Gastritis | Phase 2 / Phase 3 | Unknown | Hamamatsu University | 2003-08-01 | 2006-03-21 | |
| Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori Lansoprazole, clarithromycin, amoxicillin - Helicobacter Infections, Gastritis | Phase 3 | Unknown | Hamamatsu University | 296 | 2003-04-01 | 2006-09-11 |
| Helicobacter Pylori Eradication With a New Sequential Treatment Sequential therapy - Helicobacter Pylori Infection, Non Ulcer Dyspepsia | Phase 3 | Completed | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1000 | 2001-01-01 | 2021-03-18 |
Duodenal Ulcer (3) · Stomach Ulcer (3) · Helicobacter Infections (2) · Diarrhea (1) · Dyspepsia (1) · Fasting (1) · Gastroenteritis (1) · Nausea (1) · Peptic Ulcer (1) · Vomiting (1)
Digestive System Diseases (12) · Gastrointestinal Diseases (12) · Stomach Diseases (12) · Gastroenteritis (11) · Duodenal Diseases (4) · Intestinal Diseases (4) · Peptic Ulcer (3) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Negative Bacterial Infections (2) · Infections (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Behavior (1)
Amoxicillin (5) · Clarithromycin (4) · 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Carbohydrates (1) · Cholecalciferol (1) · Esomeprazole (1) · Lansoprazole (1) · Metronidazole (1) · Omeprazole (1) · Rabeprazole (1) · holy basil leaf extract (1)
Hamamatsu University (2) · Alexandria University (1) · Chinese University of Hong Kong (1) · Chong Kun Dang Pharmaceutical (1) · Daewoong Pharmaceutical Co. LTD. (1) · Federal University of Mato Grosso (1) · Hanmi Pharmaceutical Company Limited (1) · Hospital de Clinicas de Porto Alegre (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Mahidol University (1) · RedHill Biopharma Limited (1)
South Korea (3) · Brazil (2) · Japan (2) · Egypt (1) · Hong Kong (1) · Italy (1) · Thailand (1) · United States (1)
Angelo Zullo, MD (1) · Carlos F Francesconi, MD, PhD (1) · Guilherme B Sander, MD, MsC (1) · Justin CY Wu, MBChB(CUHK) (1) · Luiz E Mazzoleni, MD, MsC, PhD (1) · Monthira Maneerattanaporn, MD (1) · Naohito Shirai, MD., PhD (1) · Oh Young Lee, MD, Ph.D. (1) · Pubet Weeranawin, MD (1) · Robert Silverman, MD (1) · Sameh A Lashen, MD (1) · Somchai Leelakusolvong, MD (1) · Takahisa Furuta, MD, PhD (1) · Tanawat Geeratragool, MD (1)
PMID 12641522, PMID 15234753, PMID 21839884, PMID 22123802, PMID 22228948, PMID 28400848, PMID 31702802, PMID 31784469, PMID 32936964, PMID 38065906, PMID 39949051